The New York Times Magazine has a good read about companies trying to develop pot products with consistent, predictable highs. Some believe this is possible by producing formulas with specific ratios of cannabinoids and terpenes.
Based on the piece, it doesn’t seem like anyone will be mastering this anytime soon.
- One of the company’s featured in the piece is a Colorado start-up called Ebbu, which sold its assets to Canadian producer Canopy Growth in 2018. I wrote about Ebbu’s effort to invent predictable products in 2016.
- Last year, I reported that Ebbu promoted an investment structure which may have violated Colorado law. State authorities and Canopy Growth have declined to comment. (Ebbu’s former CEO has denied breaking any state or federal laws.)